Cargando…

New insights in melanoma resistance to BRAF inhibitors: a role for microRNAs

Detalles Bibliográficos
Autores principales:	Díaz-Martínez, Marta, Benito-Jardón, Lucía, Teixidó, Joaquin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226045/ https://www.ncbi.nlm.nih.gov/pubmed/30459929 http://dx.doi.org/10.18632/oncotarget.26244

Ejemplares similares

Reply to: Biological role of miR-204 and miR-211 in melanoma (published in Oncoscience, Vol 5 (7-8), July 2018)
por: Díaz-Martínez, Marta, et al.
Publicado: (2018)

Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF
por: Kim, Jae-Hyeon, et al.
Publicado: (2017)

MicroRNAs in melanoma development and resistance to target therapy
por: Fattore, Luigi, et al.
Publicado: (2017)

microRNAs and oligometastasis
por: Khodarev, Nikolai N., et al.
Publicado: (2015)

MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors
por: Motti, Maria Letizia, et al.
Publicado: (2020)

Lessons from clinical trials on triple combination of immune checkpoint inhibitors and BRAF/MEK inhibitors in BRAF-mutant melanoma
por: Maeda, Takuya, et al.
Publicado: (2023)

Circulating microRNAs in aging
por: Bonafè, Massimiliano, et al.
Publicado: (2015)

MicroRNAs as Commanders-in-Chief
por: Sáenz, José B.
Publicado: (2019)

MicroRNAs in Endometriosis: Insights into Inflammation and Progesterone Resistance
por: Hon, Jing-Xian, et al.
Publicado: (2023)

BRAF inhibitors: resistance and the promise of combination treatments for melanoma
por: Griffin, Merope, et al.
Publicado: (2017)

Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma
por: Saei, Azad, et al.
Publicado: (2019)

Clinical Implications of Acquired BRAF Inhibitors Resistance in Melanoma
por: Savoia, Paola, et al.
Publicado: (2020)

The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy
por: Dong, Linyinxue, et al.
Publicado: (2022)

TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro
por: Delyon, Julie, et al.
Publicado: (2023)

New insights into tomato microRNAs
por: Cardoso, Thaís Cunha de Sousa, et al.
Publicado: (2018)

MicroRNAs in aging male reproduction
por: Zheng, Lu, et al.
Publicado: (2022)

The Role of RNAs and microRNAs in Non-Invasive Prenatal Diagnosis
por: Farina, Antonio
Publicado: (2014)

Serum microRNAs as biomarkers for recurrence in melanoma
por: Friedman, Erica B, et al.
Publicado: (2012)

Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment
por: Mak, Gabriel, et al.
Publicado: (2014)

Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing
por: Pupo, Gulietta M., et al.
Publicado: (2017)

IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma
por: Patel, Hima, et al.
Publicado: (2021)

Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells
por: Baenke, Franziska, et al.
Publicado: (2015)

BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma
por: Li, Ying-Ying, et al.
Publicado: (2016)

Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids
por: Koroknai, Viktoria, et al.
Publicado: (2020)

BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies
por: Zhong, Jingqin, et al.
Publicado: (2022)

MicroRNAs, T follicular helper cells and inflammaging
por: Hawkes, Jason E., et al.
Publicado: (2015)

Hypothalamic microRNAs flip the switch for fertility
por: Messina, Andrea, et al.
Publicado: (2017)

MicroRNAs for podocyte injury in diabetic nephropathy
por: Morishita, Yoshiyuki
Publicado: (2021)

Role of MicroRNAs in Cancer Development and Treatment
por: Mehterov, Nikolay
Publicado: (2023)

The Roles of microRNAs in Cancer Multidrug Resistance
por: Pavlíková, Lucia, et al.
Publicado: (2022)

BET and BRAF inhibitors act synergistically against BRAF‐mutant melanoma
por: Paoluzzi, Luca, et al.
Publicado: (2016)

Prognostic significance of deregulated microRNAs in uveal melanomas
por: Falzone, Luca, et al.
Publicado: (2019)

Identification of dysregulated microRNAs in canine malignant melanoma
por: Ushio, Norio, et al.
Publicado: (2019)

Identification of Species-Specific MicroRNAs Provides Insights into Dynamic Evolution of MicroRNAs in Plants
por: Guo, Zhonglong, et al.
Publicado: (2022)

Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma
por: Spagnolo, Francesco, et al.
Publicado: (2014)

MicroRNAs as biomarkers for CNS disease
por: Rao, Pooja, et al.
Publicado: (2013)

MicroRNAs: Emerging Novel Targets of Cancer Therapies
por: Yang, Chengfeng, et al.
Publicado: (2015)

Serum microRNAs – potent biomarkers for radiation biodosimetry
por: Tomasik, Bartłomiej, et al.
Publicado: (2018)

Squaring the circle: sponging microRNAs in gastric cancer
por: Gray, Steven G.
Publicado: (2019)

The Role of microRNAs in Cancer: Functions, Biomarkers and Therapeutics
por: Tucci, Paola
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_unlvj0fhtq22kur3c488iun19n